Cogni-Krill
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80069537
- Status
- Active licence
- Licence date
- 18 May 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Huile de krill Source : Euphausia pacifica - entier Potency : 37.5 mg Docosahexaenoic acid | 250 mg | Not calculated |
| Huile de krill Source : Euphausia pacifica - entier Potency : 22.5 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia pacifica - entier Potency : 75 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de calmar Source : En entier Potency : 100 mg Eicosapentaenoic acid | 350 mg | Not calculated |
| Huile de calmar Source : En entier Potency : 200 mg Docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Source of Omega 3, DHA, EPA and an antioxidant for the maintenance of good health. Used in Herbal Medicine as a sleep aid and/or to help relieve restlessness and/or nervousness (sedative and/or calmative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80069537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.